Bioventus annual total assets
2020
2021
2022
2023
2024
2025
Bioventus Total Assets Growth & History (BVS)
Bioventus's total assets was $683.6M for fiscal 2025.
View full Bioventus company overviewBioventus annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $683.6M | −$44.4M | −6.10% |
| 2024 | 2024-12-31 | $728.0M | −$83.0M | −10.23% |
| 2023 | 2023-12-31 | $810.9M | −$561.7M | −40.92% |
| 2022 | 2022-12-31 | $1.37B | $146.8M | +11.97% |
| 2021 | 2021-12-31 | $1.23B | $731.4M | +147.92% |
| 2020 | 2020-12-31 | $494.5M | — | — |
Bioventus quarterly total assets
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-27 | $673.3M | −$33.4M | −4.73% |
| Q1 2026 | 2026-03-28 | $650.5M | −$40.9M | −5.91% |
| Q4 2025 | 2025-12-31 | $683.6M | −$44.4M | −6.10% |
| Q3 2025 | 2025-09-27 | $701.6M | −$67.9M | −8.82% |
| Q2 2025 | 2025-06-28 | $706.8M | −$85.4M | −10.78% |
| Q1 2025 | 2025-03-29 | $691.4M | −$102.8M | −12.95% |
| Q4 2024 | 2024-12-31 | $728.0M | −$83.0M | −10.23% |
| Q3 2024 | 2024-09-28 | $769.5M | −$41.6M | −5.13% |
| Q2 2024 | 2024-06-29 | $792.2M | −$44.8M | −5.35% |
| Q1 2024 | 2024-03-30 | $794.2M | −$93.2M | −10.50% |
| Q4 2023 | 2023-12-31 | $810.9M | −$561.7M | −40.92% |
| Q3 2023 | 2023-09-30 | $811.1M | −$586.9M | −41.98% |
| Q2 2023 | 2023-07-01 | $837.0M | −$371.8M | −30.76% |
| Q1 2023 | 2023-04-01 | $887.4M | −$309.7M | −25.87% |
| Q4 2022 | 2022-12-31 | $1.37B | $146.8M | +11.97% |
| Q3 2022 | 2022-10-01 | $1.40B | $743.2M | +113.51% |
| Q2 2022 | 2022-07-02 | $1.21B | $562.1M | +86.93% |
| Q1 2022 | 2022-04-02 | $1.20B | $554.1M | +86.16% |
| Q4 2021 | 2021-12-31 | $1.23B | $731.4M | +147.92% |
| Q3 2021 | 2021-10-02 | $654.8M | — | — |
| Q2 2021 | 2021-07-03 | $646.6M | — | — |
| Q1 2021 | 2021-04-03 | $643.1M | — | — |
| Q4 2020 | 2020-12-31 | $494.5M | — | — |
Bioventus total assets trends
Over the last five fiscal years, Bioventus's total assets increased from $494.5M to $683.6M, a change of $189.1M. The latest reported quarter, Q2 2026, shows $673.3M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bioventus source filings ↗